Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Sonoma Pharmaceuticals, Inc. (SNOA) had Return on Tangible Equity of -30.60% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$4.01M |
|
$-1.24M |
|
$2.55M |
|
$1.46M |
|
$5.11M |
|
$-1.09M |
|
$-0.15M |
|
$-1.24M |
|
$-1.24M |
|
$-1.24M |
|
$-1.24M |
|
$-1.24M |
|
$-1.24M |
|
$-1.09M |
|
$-1.06M |
|
1.64M |
|
1.64M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$13.11M |
|
$0.30M |
|
$1.49M |
|
$14.59M |
|
$4.85M |
|
-- |
|
$5.69M |
|
$10.54M |
|
$4.06M |
|
$4.06M |
|
$4.06M |
|
1.64M |
|
| Cash Flow Statement Financials | |
$-2.02M |
|
$-0.11M |
|
$-0.06M |
|
$5.37M |
|
$3.60M |
|
$-1.77M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.70 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
36.46% |
|
-27.27% |
|
-27.27% |
|
-- |
|
-30.93% |
|
-30.91% |
|
$-2.12M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
0.67 |
|
1.54 |
|
58.33 |
|
-30.60% |
|
|
Return on Tangible Equity |
-30.60% |
-8.50% |
|
-30.60% |
|
$2.47 |
|
$-1.29 |
|
$-1.23 |
|